Stock LLM Wiki

報告_UBS_環球晶6488_20260713

更新 2026-07-14

PDF 原檔:報告_UBS_環球晶6488_20260713_original.pdf

圖片清單(已驗證 2026-07-14)

檔名 size 分類 親眼所見內容
6488環球晶-目標價2000元-UBS_GWC_20260713_001.png 62KB 真資料圖 Upside/Downside Spectrum:GlobalWafers 6488.TWO 股價圖(標示 TWD1485.0,13 Jul)+12 個月情境帶 upside 2300.0(+55%)/base 2000.0(+35%)/downside 1100.0(-26%);下方 Value drivers (2027E) 表:12" 稼動率 90/84/75%、12" ASP 全年成長 +28/+24/+7%、GM 37.2/34.9/26.6%
6488環球晶-目標價2000元-UBS_GWC_20260713_002.png 55KB 真資料圖 GWC GM(%) 曲線 2020–2030E,三階段標注:2020–2022 COVID 產業上行(GM 升至 ~43%)、2023–2025E 晶圓業持續擴產+終端庫存(GM 降至 ~23%)、2026E 之後 better wafer cycle+美國產能 ramp+SiC 新利潤驅動(GM 升至 2029E ~50% 後略降)
6488環球晶-目標價2000元-UBS_GWC_20260713_005.png 92KB 真資料圖 Price Target(NT$,階梯線)vs Stock Price(NT$,黑線)沿革圖 2023/4–2026/6,下方 Buy/Neutral 評等區間帶:約 2025/9 前為 Neutral、之後轉 Buy;2026 年股價急漲至 ~1,350、PT 階梯上調至 800

_003.png(32KB)、_004.png(34KB)未達 40KB 門檻未逐張驗證,依 trimmed 引用位置為 Figure 7/8 PE band 與 P/BV band,未列入可嵌清單。

原始內容

GlobalWafers

Micron's LTA leading another strong and likely longer upcycle

10-year contract with Micron to power US expansion

On 9 July, GWC announced a 10-year contract with Micron supporting the latter's US capacity expansion. We believe the long-term agreement (LTA) shows supply-demand conditions could improve more rapidly in the next 2-3 years, presenting an opportunity GWC is well placed to capture owing to its US expansion. Key points: 1) Micron will pay US$0.5bn in strategic financing support to facilitate GWC's second-phase expansion in the US; we think this contract implies 200-300kwpm of committed 12" wafer demand to support Micron's US expansion in Boise and New York. 2) The blended contract pricing could be possibly 40-50% above current contract price based on our estimate, given higher US production cost. 3) The collaboration involves co-development on nextgen products, strengthening GWC's market positioning in memory.

Other large clients to follow suit in new LTA negotiation

As the possibility that 8" and 12" wafer supply will tighten by 2028 has risen, our view has been that GWC's large clients could turn increasingly aggressive towards new LTA discussions to secure supply for 2028-29. Negotiations could take place even before current contracts expire. We expect most large logic and memory clients to prioritise supply security over cost in their wafer procurement, especially as memory clients are making 80% GMs, while TSMC could report a GM of 65%-plus in Q226E. In our view, the industry outlook is turning more favourable for silicon wafer makers, owing to the stronger demand for cloud AI accelerators, server CPUs, DRAM, HBM, NAND and advanced packaging. Even the mature 6"/8" wafer market segment is recovering on supply consolidation and rising demand from the server and auto/industrial sectors.

Entering an upcycle with robust price upside

Structurally, we expect price increases in this new upcycle to follow a trajectory closer to the 2017-18 cycle. We forecast GWC's blended 12" wafer prices to increase 30%/26% in 2027/28, and 8" wafer prices to rise 25%/20% in 2027/28. Key drivers of this cycle are the AI mega-trend, re-acceleration of memory capex and more robust margin profiles across most logic and memory clients. Market share gains in advanced nodes at logic foundries, such as TSMC, could also drive ASP upside for GWC.

Valuation: reiterate Buy; raise price target from NT$800 to NT$2,000

We maintain our Buy rating and raise our P/B-based PT from NT$800 to NT$2,000. We raise 2027/28E EPS by 80%/106% to NT$45.2/87.2 respectively. In addition, we raise our target 2027E P/B from 3.6x to 8.5x to reflect: 1) the long-term ROE rising from 18.5% to 30.8%; and 2) GWC's US re-shoring opportunities, market share gains in leading edge products, and the upside in 12' SiC wafers for AI GPUs in 2028E, which we believe justifies a premium to the historical upper end of its P/B range of 7x.

Highlights (NT$m) 12/23 12/24 12/25 12/26E 12/27E 12/28E 12/29E 12/30E
Revenues 70,652 62,626 60,598 62,671 89,944 137,319 187,024 192,523
EBIT (UBS) 20,059 14,118 8,636 7,368 24,449 53,525 82,882 81,738
Net earnings (UBS) 19,772 9,846 7,312 8,025 21,592 41,674 62,341 61,483
EPS (UBS, diluted) (NT$) 43.73 20.94 15.28 16.75 45.08 87.00 130.15 128.36
DPS (net) (NT$) 20.07 11.00 5.70 6.71 18.06 34.86 0.00 0.00
Net (debt) / cash (28,942) (27,857) (54,769) (26,922) (14,490) 11,973 57,667 109,680
Profitability/valuation 12/23 12/24 12/25 12/26E 12/27E 12/28E 12/29E 12/30E
EBIT (UBS) margin% 28.4 22.5 14.3 11.8 27.2 39.0 44.3 42.5
ROIC (EBIT)% 42.7 15.2 7.3 6.1 22.5 47.8 74.5 80.7
EV/EBITDA (UBS core) x 7.6 10.5 10.6 33.0 15.6 8.4 5.9 6.2
P/E (UBS, diluted) x 11.6 24.1 24.1 80.6 29.9 15.5 10.4 10.5
Equity FCF (UBS) yield% (8.4) (14.2) (12.7) 1.4 (0.1) 1.7 6.0 12.2
Dividend yield (net)% 4.0 2.2 1.6 0.5 1.3 2.6 0.0 0.0

Source: Company accounts, LSEG Eikon, UBS estimates. Metrics marked as (UBS) have had analyst adjustments applied. Valuations: based on an average share price that year, (E): based on a share price of NT$ 1,350.00 on 10-Jul-2026

Equities Equities Equities Equities
Taiwan Taiwan Taiwan Taiwan
Semiconductors Semiconductors Semiconductors Semiconductors
12-month rating 12-month rating 12-month rating Buy
12m price target 12m price target 12m price target NT$2,000.00 Prior : NT$800.00
Price (10 Jul 2026) Price (10 Jul 2026) Price (10 Jul 2026) NT$1,350
RIC: 6488.TWO BBG: 6488 TT RIC: 6488.TWO BBG: 6488 TT RIC: 6488.TWO BBG: 6488 TT RIC: 6488.TWO BBG: 6488 TT
Trading data and key metrics Trading data and key metrics Trading data and key metrics Trading data and key metrics
52-wk range 52-wk range 52-wk range NT$1,350.00-310.00
Market cap. Market cap. Market cap. NT$645b/US$20.1b
Shares o/s Shares o/s Shares o/s 478m (ORD)
Free float Free float Free float 37%
Avg. daily volume ('000) Avg. daily volume ('000) Avg. daily volume ('000) 7.58
Avg. daily value (m) Avg. daily value (m) Avg. daily value (m) NT$6.2
Common s/h equity (12/26E) Common s/h equity (12/26E) Common s/h equity (12/26E) NT$95.2b
P/BV (12/26E) P/BV (12/26E) P/BV (12/26E) 6.8x
Net debt to EBITDA (12/26E) Net debt to EBITDA (12/26E) Net debt to EBITDA (12/26E) 1.3x
EPS (UBS, diluted) (NT$) EPS (UBS, diluted) (NT$) EPS (UBS, diluted) (NT$) EPS (UBS, diluted) (NT$)
From To %ch Cons.
12/26E 17.01 16.75 -2 21.45
12/27E 25.12 45.08 79 28.70
12/28E 42.35 87.00 105 40.00
Sunny Lin Analyst sunny.lin@ubs.com +886-2-8722 7346 Ryan Sun Associate Analyst
ryan-za.sun@ubs.com
+886-2-8722 7267
Christine Chen, CFA Associate Analyst christine.chen@ubs.com +886-2-8722 7361

Thesis Map UBS Research THESIS MAP a guide to our thinking and what´s where in this report

Pivotal Questions

UBS VIEW

EVIDENCE

WHAT´S PRICED IN?

Upside/Downside Spectrum

Company Description

Q: Will wafer supply-demand improve in 2027E/28E after the long downcycle since 2022?

The supply-demand situation for both 12" and 8" silicon wafers should improve meaningfully in 2027-28 after the 2024-25 trough. 1) We believe several wafer makers have slowed their greenfield capacity expansion since 2025. 2) The demand outlook for memory and logic is improving for the next 2-3 years led by cloud AI; we believe the industry's 12" wafer utilisation will incrementally recover from its trough of 79.1% in 2024 to 81.7/82.2% in 2025/2026E and rise further to 87.7%/93.6% in 2027E/28E. 3) We expect GWC's clients to be receptive to new LTA negotiations given increasing supply tightness; we expect supply-demand in the 8" wafer segment to also bottom out and improve from a trough of 71.9%/68.6% in 2024/25 to 78.7% in 2026E and further to 86.7%/93.7% in 2027E/28E.

Q: Will GlobalWafers' GM return to over 30% in the next three to four years?

We believe GlobalWafers' GM will recover to around 35% by 2027E, and improve further to 45.9%/50.8% by 2028E/2029E, driven by several factors, including: 1) improving supply-demand dynamics with LTA support; 2) a stronger US fab ramp by GlobalWafers, which will likely enable some share gain in advanced 12" products, as the US government is pushing for the localisation of the semiconductor supply chain; and 3) silicon carbide (SiC) opportunities for AI GPU cooling solutions should improve GlobalWafers' margin profile if the opportunity materialises in 2028E.

As the possibility that 8" and 12" wafer supply will tighten by 2028 has risen, our view has been that GWC's large clients could be more aggressive with new LTA discussions to secure supply for 2028-29. Negotiations could take place even before current contracts expire. We expect most large logic and memory clients to prioritise supply security over cost in their wafer procurement, especially as memory clients are making 80% GMs, while TSMC could report a 65%-plus GM in Q226. In our view, the industry outlook is turning more favourable for silicon wafer makers, owing to the stronger demand for cloud AI accelerators, DRAM, HBM, NAND and advanced packaging. Even the mature 6"/8" wafer market segment is recovering on supply consolidation and rising demand from the server and auto/industrial sectors.

On 9 July, GWC announced a 10-year contract with Micron supporting the latter's US capacity expansion. We believe the long-term agreement (LTA) shows supply-demand conditions could improve more rapidly in the next 2-3 years, presenting an opportunity GWC is well placed to capture owing to its US expansion. As industry supply tightens, we anticipate GWC's large clients will be more aggressive with new LTA discussions to secure supply for 2028-29.

The stock has rallied 266% YTD, which we believe reflects the improvement in the silicon wafer cycle. Now the question is how much pricing could increase in this cycle. We are more constructive as these industry dynamics evolve favorably to GWC and forecast GWC's blended 12" ASP to improve 30% in 2027E and 26% in 2028E.

Value drivers (2027E) 12" wafer utilisation rate 12" wafer ASP growth throughout the year GM
NT$2,300.00 upside 90% +28% 37.2%
NT$2,000.00 base 84% +24% 34.9%
NT$1,100.00 downside 75% +7% 26.6%
6488環球晶-目標價2000元-UBS_GWC_20260713_001

Source: UBS estimates

GlobalWafers (GWC) was founded in 2011 as a spin-off from Sino-American Silicon (SAS). It focuses on silicon raw wafer manufacturing, with a product portfolio of polished, epitaxial (EPI), annealed, diffused, non-polished, float zone (FZ) and silicon-on-insulator (SOI) types.

Figure 1: 12" wafer supply/demand model

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026E 2027E 2028E 2029E
Total inventory-adjusted demand (k pcs/mon) 5,018 5,694 6,269 5,620 6,228 7,273 7,736 6,783 6,975 7,721 8,423 9,509 10,491 11,459
YoY 13.5% 10.1% -10.3% 10.8% 16.8% 6.4% -12.3% 2.8% 10.7% 9.1% 12.9% 10.3% 9.2%
DRAM 1,083 1,180 1,254 1,312 1,341 1,496 1,638 1,424 1,548 1,792 1,924 2,087 2,346 2,652
NAND 1,366 1,495 1,544 1,444 1,500 1,618 1,737 1,388 1,294 1,322 1,349 1,355 1,402 1,477
Logic & others 2,703 2,851 3,284 3,209 3,624 4,216 4,344 3,957 4,196 4,629 5,157 5,968 6,594 7,271
Inventory adjustment -135 168 188 -345 -238 -58 18 13 -63 -21 -8 0 0 0
Total output (k pcs/mon) 5,143 5,605 6,281 6,032 6,490 7,324 7,752 7,419 7,299 7,842 8,758 9,519 10,043 10,472
YoY 9.0% 12.1% -4.0% 7.6% 12.8% 5.9% -4.3% -1.6% 7.4% 11.7% 8.7% 5.5% 4.3%
Shin-Etsu 1,533 1,729 2,043 1,880 1,997 2,186 2,295 2,369 2,409 2,409 2,625 2,740 2,820 2,902
SUMCO 1,311 1,406 1,562 1,522 1,683 1,880 1,910 1,699 1,607 1,775 1,936 2,022 2,045 2,069
Siltronic 816 956 1,021 890 944 1,039 1,075 849 850 887 1,017 1,156 1,266 1,320
GlobalWafers 712 722 792 748 815 986 1,034 1,008 895 950 1,062 1,240 1,350 1,485
SK Siltron 770 791 863 993 1,052 1,128 1,256 1,213 1,146 1,093 1,142 1,187 1,300 1,347
China and others effective capacity 0 0 0 0 0 104 182 282 392 729 976 1,174 1,261 1,349
Total Industry Capacity 5,137 5,623 6,347 6,989 7,146 7,730 8,008 8,289 8,816 9,446 10,243 10,837 11,209 11,549
Industry Utilization% 97.7% 101.3% 98.8% 80.4% 87.1% 94.1% 96.6% 81.8% 79.1% 81.7% 82.2% 87.7% 93.6% 99.2%

Source: Company data, UBS estimates. Note: China and others refers to NSIG and other suppliers. Mon = month.

Figure 2: 8" wafer supply/demand model

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026E 2027E 2028E 2029E
Wafer demand
Total inventory-adjusted demand (k pcs/mon) 4,297 4,550 5,291 5,636 4,943 4,980 5,958 6,050 4,631 4,120 3,989 4,303 4,681 5,093 5,401
YoY 5.9% 16.3% 6.5% -12.3% 0.7% 19.6% 1.5% -23.5% -11.0% -3.2% 7.9% 8.8% 8.8% 6.0%
Inventory adjustment (k pcs/mon) -100 -50 30 30 -130 -60 70 150 0 0 -20 0 0 10 10
Total capacity (k pcs/mon) 4,920 5,136 5,202 5,581 5,792 5,939 6,019 6,328 5,973 5,726 5,814 5,469 5,401 5,435 5,435
YoY 4.4% 1.3% 7.3% 3.8% 2.5% 1.3% 5.1% -5.6% -4.1% 1.5% -5.9% -1.2% 0.6% 0.0%
Shin-Etsu 1,200 1,236 1,285 1,363 1,403 1,432 1,460 1,471 1,133 869 752 752 752 752 752
SUMCO 1,250 1,288 1,200 1,200 1,200 1,250 1,163 1,375 1,211 1,038 1,175 800 700 700 700
GlobalWafers 1,000 1,032 1,095 1,106 1,117 1,128 1,139 1,151 1,162 1,174 1,174 1,174 1,174 1,174 1,174
Siltronic 650 650 650 650 650 650 650 650 650 650 650 650 650 650 650
SK Siltron 550 630 649 655 662 669 675 682 689 696 696 696 696 696 696
WaferWorks 200 200 218 297 388 413 476 500 500 500 500 500 500 500 500
Ferrotec JV 0 0 51 100 100 100 100 100 100 100 100 100 100 100
China and others effective capacity 70 100 105 259 272 298 355 399 528 700 767 798 830 863 863

Industry Utilization %

87.3% 88.6% 101.7% 101.0% 85.3% 83.9% 99.0% 95.6% 77.5% 71.9% 68.6% 78.7% 86.7% 93.7% 99.4%

Source: Company data, UBS estimates. Note: China and others refers to NSIG and other suppliers. Mon = month.

Figure 3: GWC's GM outlook improving with a better cycle, stronger ramp-up of US capacity, and SiC opportunities

6488環球晶-目標價2000元-UBS_GWC_20260713_002

Source: UBS estimates

Forecast changes

Figure 4: Revisions to our earnings estimates

(NT$m) 2026E New 2027E 2028E 2026E Old 2027E 2028E 2026E Change 2027E 2028E
Revenue 62,671 89,944 137,319 63,958 80,486 104,995 -2% 12% 31%
- YoY chg 3% 44% 53% 6% 26% 30%
Revenue (US$m) 1,958 2,811 4,291 1,999 2,515 3,281 -2% 12% 31%
- YoY chg 1% 44% 53% 4% 26% 30%
Gross profit 13,501 31,346 62,991 13,704 21,803 34,623 -1% 44% 82%
- Gross margin 21.5% 34.9% 45.9% 21.4% 27.1% 33.0%
Operating profit 7,368 24,449 53,525 7,816 15,379 26,773 -6% 59% 100%
- Operating margin 11.8% 27.2% 39.0% 12.2% 19.1% 25.5%
Pretax profit 10,519 28,789 55,565 10,668 16,019 27,013
Net profit 8,025 21,592 41,674 8,137 12,014 20,260 -1% 80% 106%
- Net margin 12.8% 24.0% 30.3% 12.7% 14.9% 19.3%
EPS (NT$) 16.78 45.16 87.16 17.02 25.13 42.37 -1% 80% 106%
- YoY chg 10% 169% 93% 11% 48% 69%

Source: UBS estimates. Note: Our EPS estimates here are based on basic EPS, and may differ from the table on the cover page.

Figure 5: Our earnings estimates vs consensus

UBSe UBSe UBSe Consensus Consensus Consensus Difference Difference Difference
(NT$m) 2026E 2027E 2028E 2026F 2027F 2028F 2026E 2027E 2028E
Revenue 62,671 89,944 137,319 64,646 81,288 95,547 -3% 11% 44%
- YoY chg 3% 44% 53% 7% 26% 18%
Gross profit 13,501 31,346 62,991 14,972 23,311 31,219 -10% 34% 102%
- Gross margin 21.5% 34.9% 45.9% 23.2% 28.7% 32.7%
Operating profit 7,368 24,449 53,525 8,799 16,326 23,225 -16% 50% 130%
- Operating margin 11.8% 27.2% 39.0% 13.6% 20.1% 24.3%
Net profit 8,025 21,592 41,674 9,880 14,640 19,868 -19% 47% 110%
- Net margin 12.8% 24.0% 30.3% 15.3% 18.0% 20.8%
EPS (NT$) 16.78 45.16 87.16 20.57 29.96 41.56 -18% 51% 110%
- YoY chg 10% 169% 93% 35% 46% 39%

Source: UBS estimates, Visible Alpha. Note: Our EPS estimates here are based on basic EPS, and may differ from the table on the cover page.

Figure 6: Our earnings forecasts

(NT$ m) 2025 Q126 Q226E Q326E Q426E 2026E Q127E Q227E Q327E Q427E 2027E 2028E 2029E 2030E
Revenue 60,598 13,985 15,214 16,274 17,198 62,671 19,238 21,162 23,898 25,646 89,944 137,319 187,024 192,523
- YoY chg (%) -3% -10% -5% 12% 19% 3% 38% 39% 47% 49% 44% 53% 36% 3%
- QoQ chg (%) - -4% 9% 7% 6% - 12% 10% 13% 7% - - - -
Revenue (US$m) 1,930 437 475 509 537 1,958 601 661 747 801 2,811 4,291 5,845 6,016
- YoY chg (%) -1% -7% -8% 5% 16% 1% 38% 39% 47% 49% 44% 53% 36% 3%
- QoQ chg (%) - -5% 9% 7% 6% - 12% 10% 13% 7% - - - -
Blended ASP (US$/pcs)
<6" 6.9 6.9 6.9 6.9 6.9 6.9 6.9 6.9 6.9 6.9 6.9 7.0 6.9 6.9
6" 9.2 9.0 9.0 9.0 9.0 9.0 9.2 9.5 9.8 10.1 9.7 10.9 12.2 12.7
8" 56.6 54.1 54.1 54.1 55.7 54.5 59.6 63.7 67.6 70.9 65.6 80.4 93.0 92.2
12" 100.5 94.7 94.5 97.3 100.2 96.9 107.3 114.8 124.0 133.9 120.4 159.4 195.1 208.4
Wafer shipment (k pcs)
<6" - YoY chg (%) 9,030 4% 2,310 2,310 2,310 2,310 9,240 2% 2,310 2,310 2,310 2,310 9,240 0% 10,080 9% 10,080 0% 10,080 0%
6" - YoY chg (%) 12,011 4% 3,073 3,073 3,073 3,073 12,290 2% 3,073 3,073 3,073 3,073 12,290 0% 13,407 9% 13,407 0% 13,407 0%
8" - YoY chg (%) 8,756 3% 2,100 2,132 2,229 2,262 8,724 0% 2,423 2,520 2,617 2,585 10,145 16% 11,341 12% 11,567 2% 10,985 -5%
12" - YoY chg (%) 11,457 6% 2,682 3,076 3,272 3,403 12,433 9% 3,578 3,701 3,964 4,010 15,252 23% 17,304 13% 19,116 10% 19,297 1%
Gross profit 14,624 2,914 3,284 3,499 3,805 13,501 5,152 6,898 9,038 10,258 31,346 62,991 95,033 94,164
- Gross margin 24.1% 20.8% 21.6% 21.5% 22.1% 21.5% 26.8% 32.6% 37.8% 40.0% 34.9% 45.9% 50.8% 48.9%
Operating profit 8,636 1,475 1,751 1,903 2,239 7,368 3,590 5,240 7,243 8,376 24,449 53,525 82,882 81,738
- OP margin 14.3% 10.5% 11.5% 11.7% 13.0% 11.8% 18.7% 24.8% 30.3% 32.7% 27.2% 39.0% 44.3% 42.5%
Non-op income 880 871 960 660 660 3,151 1,460 960 960 960 4,340 2,040 240 240
Pre-tax profit 9,516 2,347 2,711 2,563 2,899 10,519 5,050 6,200 8,203 9,336 28,789 55,565 83,122 81,978
Net profit 7,312 1,896 2,033 1,922 2,174 8,025 3,787 4,650 6,152 7,002 21,592 41,674 62,341 61,483
- Net margin
Reported EPS (NT$) 15.29 3.97 4.25 4.02 4.55 16.78 7.92 9.73 12.87 14.64 45.16 87.16 130.39 128.60
- YoY chg (%) -27% 30% 21% -2% -1% 10% 100% 129% 220% 222% 169% 93% 50% -1%
- QoQ chg (%) - -14% 7% -5% 13% - 74% 23% 32% 14% - - - -

Source: Company data, UBS estimates. Note: Our EPS estimates here are based on basic EPS, and may differ from the table on the cover page.

Figure 7: GWC 12-month forward PE band (x)

6488環球晶-目標價2000元-UBS_GWC_20260713_003

Source: LSEG, UBS

Figure 8: GWC 12-month forward P/BV band (x)

6488環球晶-目標價2000元-UBS_GWC_20260713_004

Source: LSEG, UBS

GlobalWafers (6488.TWO)

Income Statement (NT$m) 12/23 12/24 12/25 12/26E %ch 12/27E %ch 12/28E 12/29E 12/30E
Revenues 70,652 62,626 60,598 62,671 3.4 89,944 43.5 137,319 187,024 192,523
Gross profit 26,441 19,804 14,624 13,501 -7.7 31,346 132.2 62,991 95,033 94,164
EBITDA (UBS) 26,792 22,188 17,585 20,312 15.5 41,715 105.4 75,536 107,519 101,297
Depreciation & amortisation (6,734) (8,069) (8,949) (12,944) -44.6 (17,266) -33.4 (22,011) (24,638) (19,559)
EBIT (UBS) 20,059 14,118 8,636 7,368 -14.7 24,449 231.8 53,525 82,882 81,738
Associates & investment income 0 0 0 30 - 40 33.3 40 40 40
Other non-operating income 3,822 (2,789) 1,412 3,238 129.3 4,500 39.0 2,200 400 400
Net interest 2,616 1,100 (532) (116) 78.1 (200) -72.0 (200) (200) (200)
Exceptionals (incl goodwill) 0 0 0 0 - 0 - 0 0 0
Pre-tax profit 26,496 12,429 9,516 10,519 10.5 28,789 173.7 55,565 83,122 81,978
Tax (6,727) (2,590) (2,205) (2,494) -13.1 (7,197) -188.6 (13,891) (20,780) (20,495)
Profit after tax 19,770 9,839 7,312 8,025 9.8 21,592 169.1 41,674 62,341 61,484
Preference dividends 0 0 0 0 - 0 - 0 0 0
Minorities 2 7 0 - 0 0.0 0 0 0
Extraordinary 0 0 0 0 0 - 0 - 0 0 0
items Net earnings (local GAAP) 19,772 9,846 7,312 8,025 9.7 21,592 169.1 41,674 62,341 61,483
Net earnings (UBS) 19,772 9,846 7,312 8,025 9.7 21,592 169.1 41,674 62,341 61,483
Tax rate (%) 25.4 20.8 23.2 23.7 2.3 25.0 5.4 25.0 25.0 25.0
Per Share (NT$) 12/23 12/24 12/25 12/26E %ch 12/27E %ch 12/28E 12/29E 12/30E
EPS (UBS, diluted) 43.73 20.94 15.28 16.75 9.6 45.08 169.1 87.00 130.15 128.36
EPS (local GAAP, diluted) 43.73 20.94 15.28 16.75 9.6 45.08 169.1 87.00 130.15 128.36
EPS (UBS, basic) 45.41 16.37 16.78 45.16 87.16 128.60
DPS (net) (NT$) 20.07 22.58 5.70 6.71 2.5 18.06 169.1 34.86 130.39 0.00
Cash EPS (UBS, diluted) 1 58.63 11.00 38.09 33.98 43.78 17.8 28.8 81.12 169.1 85.3 132.96 181.59 0.00 169.20
Book value per share 152.37 208.73 195.14 199.15 2.1 233.82 17.4 293.93 381.69 456.64
Average shares (diluted) 452 470 479 479 0.1 479 0.0 479 479 479
Balance Sheet (NT$m) 12/23 12/24 12/25 12/26E %ch 12/27E %ch 12/28E 12/29E 12/30E
Cash and equivalents Other current assets 26,175 63,927 38,958 41,534 19,486 67,144 39,744 51,363 104.0 -23.5 52,176 77,184 31.3 50.3 78,639 115,064 124,333 152,764 176,346 150,037
Total current assets 90,101 80,492 86,629 91,107 129,360 42.0 193,702 277,097 326,383
Net tangible fixed assets 72,251 119,074 107,241 104,696 5.2 -2.4 97,431 -6.9 85,419 66,782 53,223
Net intangible fixed assets 2,347 2,448 2,319 2,357 1.7 2,357 0.0 2,357 2,357 2,357
Investments / other assets 24,290 22,566 22,153 24,677 11.4 29,281 18.7 36,045 42,776 42,269
Total assets 188,988 224,581 218,343 222,838 258,429 16.0 317,524 389,011 424,232
Trade payables & other ST liabilities 33,699 35,927 23,098 28,392 2.1 31,032 9.3 37,369 42,992 44,106
Short term debt 40,575 29,137 31,010 37,445 22.9 20.7 37,445 0.0 37,445 37,445 37,445
Total current liabilities 74,274 65,065 54,109 65,836 21.7 68,477 4.0 74,814 80,436 81,550
Long term debt 29,221 0.0 29,221
14,542 37,678 43,244 29,221 -32.4 29,221 29,221
Other long term liabilities 33,719 30,810 27,695 32,569 17.6 48,941 50.3 72,960 96,865 95,137
Preferred shares Total liabilities (incl pref 0 122,534 0 133,553 0 125,048 0 127,626 - 2.1 0 146,639 - 14.9 0 176,995 0 206,523 0 205,908
shares) Common s/h equity 66,450 91,031 95,215 17.4 (4) 182,492
Minority interests 4 (3) 93,299 (3) (4) 2.1 -2.0 111,793 (4) 0.0 140,532 (4) 218,328 (4)
Total liabilities & equity 188,988 224,581 218,343 222,838 2.1 258,429 16.0 317,524 389,011 424,232
Cash Flow (NT$m) 12/23 12/24 12/25 12/26E %ch 12/27E %ch 12/28E 12/29E 12/30E
Net income (before pref divs) 19,772 9,846 7,312 8,025 9.7 21,592 169.1 41,674 62,341 61,483
Depreciation & amortisation 6,734 8,069 8,949 12,944 44.6 17,266 33.4 22,011 24,638 19,559
Net change in working capital (708) (1,485) (21) 3,702 - (8,561) - -257.3 (11,748) (11,810) 1,395
Other operating Operating cash flow (7,862) 306 (3,125) (5,884) -88.3 (21,027) 9,269 (30,856) 21,081 (30,710) 44,459 2,241
17,936 16,737 13,114 18,786 43.2 -50.7 84,678
Tangible capital expenditure (36,475) 0 (47,940) (33,411) 0 (10,000) 70.1 (10,000) 0.0 (10,000) (6,000) (6,000)
Intangible capital expenditure 0 0 - 0 - 0 0
Net (acquisitions) & disposals 53 (36,620) (6,846) 25,166 (106) 13 - 0 0 - - 0 0 0 0 0
Other investing (531) 15,610 - 0 0
Investing cash flow (73,042) (29,620) (34,049) 5,623 - (10,000) - (10,000) (6,000) (6,000)
Equity dividends paid (6,964) 0 (8,748) (5,259) 0 (3,681) 30.0 (3,210) 12.8 (8,637) 0 (16,669) 0 (24,936) 0
Share issues / (buybacks) 21,891 - -
Other financing (210) (145) 0 6,354 0 16,373 157.7 24,019 23,905 (1,729)
Change in debt & pref shares 5,270 12,743 (172) 6,734 (7,812) - - 0 - 0 0 0
Financing cash flow Cash flow inc/(dec) in (1,903) 25,740 1,303 (5,139) - - 13,163 - -35.5 15,382 7,236 (26,665)
cash (57,009) 12,857 (19,631) 19,270 12,432 0 26,463 45,694 0 52,013 0
FX / non cash items cash 2,660 (74) 159 988 NM - - 0
(54,349) 12,784 20,258 12,432 45,694
Balance sheet inc/(dec) in (19,472) 26,463
-38.6 52,013

Source: Company accounts, UBS estimates. (UBS) metrics use reported figures which have been adjusted by UBS analysts. 1 Cash EPS (UBS, diluted) is calculated using UBS net income adding back depreciation and amortization.

GlobalWafers (6488.TWO)

Valuation (x) 12/23 12/24 12/25 12/26E 12/27E 12/28E 12/29E 12/30E
P/E (local GAAP, diluted) 11.6 24.1 24.1 NM 29.9 15.5 10.4 10.5
P/E (UBS, diluted) 11.6 24.1 24.1 80.6 29.9 15.5 10.4 10.5
P/CEPS 8.3 12.3 10.1 30.8 16.6 10.1 7.4 8.0
Equity FCF (UBS) yield% (8.4) (14.2) (12.7) 1.4 (0.1) 1.7 6.0 12.2
Dividend yield (net)% 4.0 2.2 1.6 0.5 1.3 2.6 0.0 0.0
P/BV 3.3 2.4 1.9 6.8 5.8 4.6 3.5 3.0
EV/revenues (core) 2.9 3.7 3.1 NM 7.2 4.6 3.4 3.3
EV/EBITDA (UBS core) 7.6 10.5 10.6 33.0 15.6 8.4 5.9 6.2
EV/EBIT (core) 10.2 16.6 21.6 91.1 26.6 11.8 7.6 7.7
EV/OpFCF (core) NM NM NM 47.9 28.1 11.7 7.0 6.5
EV/op. invested capital 4.4 2.5 1.6 5.6 6.0 5.6 5.7 6.2
Enterprise value (NT$m) 12/23 12/24 12/25 12/26E 12/27E 12/28E 12/29E 12/30E
Market cap. 219,992 219,805 160,364 645,454 645,454 645,454 645,454 645,454
Net debt (cash) (1,129) 28,400 41,313 40,845 20,706 1,258 1,258 1,258
Buy out of minorities 4 0 0 0 0 0 0 0
Pension provisions/other 0 0 0 0 0 0 0 0
Total enterprise value 218,868 248,205 201,677 686,299 666,160 646,712 646,712 646,712
Non core assets (14,184) (14,280) (14,811) (15,481) (15,462) (15,444) (15,425) (15,407)
Core enterprise value 204,684 233,924 186,866 670,818 650,697 631,268 631,287 631,306
Growth (%) 12/23 12/24 12/25 12/26E 12/27E 12/28E 12/29E 12/30E
Revenue 0.5 (11.4) (3.2) 3.4 43.5 52.7 36.2 2.9
EBITDA (UBS) (13.8) (17.2) (20.7) 15.5 105.4 81.1 42.3 (5.8)
EBIT (UBS) (19.7) (29.6) (38.8) (14.7) NM 118.9 54.8 (1.4)
EPS (UBS, diluted) 27.9 (52.1) (27.0) 9.6 169.1 93.0 49.6 (1.4)
Net DPS 25.4 (45.2) (48.2) 17.8 169.1 93.0 (100.0) -
Margins & Profitability (%) 12/23 12/24 12/25 12/26E 12/27E 12/28E 12/29E 12/30E
Gross profit margin 37.4 31.6 24.1 21.5 34.9 45.9 50.8 48.9
EBITDA margin 37.9 35.4 29.0 32.4 46.4 55.0 57.5 52.6
EBIT (UBS) margin 28.4 22.5 14.3 11.8 27.2 39.0 44.3 42.5
Net earnings (UBS) margin 28.0 15.7 12.1 12.8 24.0 30.3 33.3 31.9
ROIC (EBIT) 42.7 15.2 7.3 6.1 22.5 47.8 74.5 NM
ROIC post tax 31.9 12.0 5.6 4.7 16.9 35.8 55.9 60.5
ROE (UBS) 32.7 12.5 7.9 8.5 20.9 33.0 38.6 30.7
Capital structure & Coverage (x) 12/23 12/24 12/25 12/26E 12/27E 12/28E 12/29E 12/30E
Net debt / EBITDA 1.1 1.3 3.1 1.3 0.3 (0.2) (0.5) (1.1)
Net debt / total equity% 43.6 30.6 58.7 28.3 13.0 (8.5) (31.6) (50.2)
Net debt / (net debt + total equity)% 30.3 23.4 37.0 22.0 11.5 (9.3) (46.2) NM
Net debt/EV% (0.5) 11.4 20.5 6.0 3.1 0.2 (5.4) (12.9)
Capex / depreciation% NM NM NM 77.3 57.9 45.4 24.4 30.7
Capex / revenue% NM NM NM 16.0 11.1 7.3 3.2 3.1
EBIT / net interest - - 16.2 63.6 NM NM NM NM
Dividend cover (UBS) 2.3 2.1 2.9 2.5 2.5 2.5 - -
Div. payout ratio (UBS)% 44.2 48.7 34.8 40.0 40.0 40.0 - -
Revenues by division (NT$m) 12/23 12/24 12/25 12/26E 12/27E 12/28E 12/29E 12/30E
Raw wafers 70,652 62,626 60,598 62,671 89,944 137,319 187,024 192,523
Others 0 0 0 0 0 0 0 0
Total 70,652 62,626 60,598 62,671 89,944 137,319 187,024 192,523
(NT$m)
EBIT (UBS) by division 12/23 12/24 12/25 12/26E 12/27E 12/28E 12/29E 12/30E
Raw wafers Others 20,059 0 14,118 0 8,636 0 7,368 0 24,449 0 53,525 0 82,882 0 81,738 0
Total 53,525 82,882
20,059 14,118 8,636 7,368 24,449 81,738

Source: Company accounts, UBS estimates. (UBS) metrics use reported figures which have been adjusted by UBS analysts.

Forecast returns

Forecast price appreciation 48.1%
Forecast dividend yield 0.5%
Forecast stock return 48.6%
Market return assumption 6.3%
Forecast excess return 42.4%

Company Description

GlobalWafers (GWC) was founded in 2011 as a spin-off from Sino-American Silicon (SAS). It focuses on silicon raw wafer manufacturing, with a product portfolio of polished, epitaxial (EPI), annealed, diffused, non-polished, float zone (FZ) and silicon-on-insulator (SOI) types. The company has around a 17% market share of the global silicon wafer market, and ranks as the third-largest, following several acquisitions (GlobiTech in 2008, Covalent in 2012, Topsil and SunEdison Semiconductor in 2016).

Valuation Method and Risk Statement

For GlobalWafers, we derive our price target using a target PB multiple relative to industry peers. We believe GlobalWafers faces a variety of upside and downside risks, including volatile end demand, intense competition, high capital investment, industry capacity expansion and FX uncertainty. Key risks we identify for silicon-wafer manufacturers include lower semiconductor demand due to economic contraction, lower wafer demand caused by rapid miniaturisation progress, inventory adjustments in the supply chain, price competition stemming from oversupply caused by expansion of production capacity, the growing presence of Chinese manufacturers and FX fluctuation.

Quantitative Research Review

UBS Global Research publishes a quantitative assessment of its analysts' responses to certain questions about the likelihood of an occurrence of a number of short term factors in a product known as the 'Quantitative Research Review'. The views for this month can be found below. Views contained in this assessment on a particular stock reflect only the views on those short term factors which are a different timeframe to the 12-month timeframe reflected in any equity rating set out in this note. For previous responses please make reference to (i) previous UBS Global Research reports; and (ii) where no applicable research report was published that month, the Quantitative Research Review which can be found at https://neo.ubs.com/quantitative, or contact your UBS sales representative for access to the report or the Quantitative Research Team on ubs-quant-answers@ubs.com. A consolidated report which contains all responses is also available and again you should contact your UBS sales representative for details and pricing or the Quantitative Research Team on the email above.

GlobalWafers

Question Response
1. Is the industry structure facing the firm likely to improve or deteriorate over the next six months? Rate on a scale of 1-5 (1 = getting worse, 3 = no change, 5 = getting better, N/A = no view) 4
2. Is the regulatory/government environment facing the firm likely to improve or deteriorate over the next six months? Rate on a scale of 1-5 (1 = getting tougher 3 = no change, 5 = getting better, N/A = no view) 3
3. Over the last 3-6 months in broad terms have things been improving/no change/getting worse for this stock? Rate on a scale of 1-5 (1 = getting a lot worse, 3 = not much change, 5 = getting a lot better, N/A = no view) 4
4. Relative to the current CONSENSUS EPS forecast, is the next company EPS update likely to lead to: (1 = negative surprise vs consensus, 3 = in-line with consensus, 5 = positive surprise vs consensus expectations, N/A = no view) 3
5. What's driving the difference?
6. Relative to YOUR current earnings forecast, is there relatively greater risk at the next earnings result of:(1 = downside skew risk to earnings, 3 = equal upside or downside risk to earnings, 5 = upside skew risk to earnings, N/A = no view) 3
7. What's driving the difference?
8. Is there an upcoming catalyst for the company over the next three months?
9. Is there an actual or approximate date for the catalyst?
10. Is the catalyst date an actual or approximate date?
11. What is the catalyst?

Required Disclosures

This document has been prepared by UBS Securities Pte. Ltd., Taipei Branch, an affiliate of UBS AG. UBS AG, its subsidiaries, branches and affiliates, including former Credit Suisse AG and its subsidiaries, branches and affiliates are referred to herein as "UBS".

For information on the ways in which UBS manages conflicts and maintains independence of its UBS Global Research product; historical performance information; certain additional disclosures concerning UBS Global Research recommendations; and terms and conditions for certain third party data used in research report, please visit https://www.ubs.com/disclosures. Unless otherwise indicated, information and data in this report are based on company disclosures including but not limited to annual, interim, quarterly reports and other company announcements. The figures contained in performance charts refer to the past; past performance is not a reliable indicator of future results. Additional information will be made available upon request. UBS Securities Co. Limited is licensed to conduct securities investment consultancy businesses by the China Securities Regulatory Commission. UBS acts or may act as principal in the debt securities (or in related derivatives) that may be the subject of this report. This recommendation was finalized on: 13 July 2026 10:22 AM GMT. UBS has designated certain UBS Global Research department members as Derivatives Research Analysts where those department members publish research principally on the analysis of the price or market for a derivative, and provide information reasonably sufficient upon which to base a decision to enter into a derivatives transaction. Where Derivatives Research Analysts coauthor research reports with Equity Research Analysts or Economists, the Derivatives Research Analyst is responsible for the derivatives investment views, forecasts, and/or recommendations. Quantitative Research Review: UBS Global Research publishes a quantitative assessment of its analysts' responses to certain questions about the likelihood of an occurrence of a number of short term factors in a product known as the 'Quantitative Research Review'. Views contained in this assessment on a particular stock reflect only the views on those short term factors which are a different timeframe to the 12-month timeframe reflected in any equity rating set out in this note. For the latest responses, please see the Quantitative Research Review Addendum at the back of this report, where applicable. For previous responses please make reference to (i) previous UBS Global Research reports; and (ii) where no applicable research report was published that month, the Quantitative Research Review which can be found at https://neo.ubs.com/ quantitative, or contact your UBS sales representative for access to the report or the Quantitative Research Team on ubs-quantanswers@ubs.com. A consolidated report which contains all responses is also available and again you should contact your UBS sales representative for details and pricing or the Quantitative Research team on the email above.